Biophytis SA (BPTSY)
8.02
-1.40
(-14.86%)
USD |
OTCM |
May 10, 16:00
Biophytis Enterprise Value: 2.214M for May 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 2.214M |
| May 09, 2024 | 2.615M |
| May 08, 2024 | 2.615M |
| May 07, 2024 | 2.492M |
| May 06, 2024 | 2.065M |
| May 03, 2024 | 2.480M |
| May 02, 2024 | 2.480M |
| May 01, 2024 | 2.443M |
| April 30, 2024 | 2.523M |
| April 29, 2024 | 2.523M |
| April 26, 2024 | 2.351M |
| April 25, 2024 | 2.271M |
| April 24, 2024 | 2.696M |
| April 23, 2024 | 2.835M |
| April 22, 2024 | 2.729M |
| April 19, 2024 | 3.240M |
| April 18, 2024 | 3.652M |
| April 17, 2024 | 3.244M |
| April 16, 2024 | 3.246M |
| April 15, 2024 | 3.709M |
| April 12, 2024 | 3.754M |
| April 11, 2024 | 3.691M |
| April 10, 2024 | 3.754M |
| April 09, 2024 | 4.699M |
| April 08, 2024 | 3.584M |
| Date | Value |
|---|---|
| April 05, 2024 | 3.858M |
| April 04, 2024 | 3.903M |
| April 03, 2024 | 3.820M |
| April 02, 2024 | 4.045M |
| April 01, 2024 | 4.042M |
| March 28, 2024 | 3.938M |
| March 27, 2024 | 3.927M |
| March 26, 2024 | 4.271M |
| March 25, 2024 | 4.223M |
| March 22, 2024 | 4.294M |
| March 21, 2024 | 4.437M |
| March 20, 2024 | 4.999M |
| March 19, 2024 | 4.268M |
| March 18, 2024 | 4.579M |
| March 15, 2024 | 5.398M |
| March 14, 2024 | 5.232M |
| March 13, 2024 | 5.495M |
| March 12, 2024 | 5.514M |
| March 11, 2024 | 5.361M |
| March 08, 2024 | 5.130M |
| March 07, 2024 | 5.360M |
| March 06, 2024 | 5.424M |
| March 05, 2024 | 4.699M |
| March 04, 2024 | 5.15M |
| March 01, 2024 | 5.188M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.4817M
Minimum
Nov 29 2022
183.31M
Maximum
Feb 16 2021
37.63M
Average
10.85M
Median
Enterprise Value Benchmarks
| Edap TMS SA | 222.03M |
| DBV Technologies SA | 9.781M |
| Cellectis SA | 49.97M |
| Genfit SA | 172.56M |
| Adaptimmune Therapeutics PLC | 129.51M |
Enterprise Value Related Metrics
| Earnings Yield | -1.62K% |